Filing Details

Accession Number:
0001225208-18-005503
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-06 18:41:38
Reporting Period:
2018-03-02
Accepted Time:
2018-03-06 18:41:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
701221 Cigna Corp CI Hospital & Medical Service Plans (6324) 061059331
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1318751 David Cordani 900 Cottage Grove Road
Bloomfield CT 06002
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.25 Par Value Acquisiton 2018-03-02 67,070 $0.00 372,076 No 4 A Direct
Common Stock, $.25 Par Value Disposition 2018-03-02 30,301 $192.44 341,775 No 4 F Direct
Common Stock, $.25 Par Value Disposition 2018-03-05 2,500 $192.73 339,275 No 4 S Direct
Common Stock, $.25 Par Value Disposition 2018-03-05 5,000 $190.24 334,275 No 4 S Direct
Common Stock, $.25 Par Value Disposition 2018-03-05 10,899 $191.36 323,376 No 4 S Direct
Common Stock, $.25 Par Value Disposition 2018-03-05 18,370 $192.12 305,006 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $.25 Par Value 1,640 Indirect By 401(k)
Footnotes
  1. The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2015-2017 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
  2. Represents shares withheld to satisfy tax obligations upon vesting.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
  4. Represents the weighted average price of the shares sold. The prices actually received ranged from $192.64 to $192.90 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
  5. Represents the weighted average price of the shares sold. The prices actually received ranged from $189.64 to $190.61 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
  6. Represents the weighted average price of the shares sold. The prices actually received ranged from $190.65 to $191.64 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
  7. Represents the weighted average price of the shares sold. The prices actually received ranged from $191.642 to $192.63 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
  8. Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.